All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Completed, but no date | 2004-004181-32 | FOLFOX 4 + CETUXIMAB IN UNTREATED PATIENTS WITH ADVANCED COLO-RECTAL TUMOUR. A PHASE II MULTICENTER STUDY OF THE GRUPPO ONCOLOGICO DELL'ITALIA MERIDIONALE | bad-data | |
Ongoing | 2005-002181-11 | FOLFIRI vs XELIRI in the treatment of advanced colo-rectal untreated carcinoma: a phase II randomized study of the Gruppo Oncologico dell'Italia Meridionale | not-yet-due | |
Ongoing | 2006-002737-21 | A randomized phase II study in the advanced or metastatic transitional cell urotelium carcinoma between Gemcitabine + Cisplatin e Gemcitabine + Cisplatino + Taxolo | not-yet-due | |
Ongoing | 2006-003746-42 | Immunotherapy vs immuno-chemotherapy in patients with metastatic kidney carcinoma | not-yet-due | |
Ongoing | 2006-003752-38 | A phase II study of Capecitabine in combination with oral vinorelbine in advanced Breast Cancer | not-yet-due | |
Completed, but no date | 2006-003775-13 | A phase II study of Capecitabine in combination with Cisplatin in advanced head and neck Cancer | bad-data | |
Ongoing | 2006-004084-66 | A phase II study on the efficacy and safety of topotecan in the treatment of patients with brain metastases | not-yet-due | |
Completed, but no date | 2006-004751-38 | Vaccine with dendritic cells pulsed tumoral cell line or with autologue tumor in patients with kidney carcinoma | bad-data |